USA Genetic Virus Vector Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Genetic Virus Vector market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Genetic Virus Vector market. Detailed analysis of key players, along with key growth strategies adopted by Genetic Virus Vector industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Oxford BioMedica

    • Brammer Bio

    • REGENXBIO Inc, Kaneka Eurogentec SA

    • uniQure NV

    • Cobra Biologics

    • Cell and Gene Therapy Catapult

    • GENERAL ELECTRIC COMPANY

    • FUJIFILM Diosynth Biotechnologies USA, Sanofi

    • Lonza

    • Merck KGaA

    • FinVector Vision Therapies

    • Spark Therapeutics

    By Type:

    • Retroviral Vectors

    • Adenoviral Vectors

    • Adeno-Associated Viral Vectors

    • Other

    By End-User:

    • Gene Therapy

    • Vaccinology

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Genetic Virus Vector Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Genetic Virus Vector Market Size and Growth Rate of Retroviral Vectors from 2016 to 2027

      • 1.3.2 USA Genetic Virus Vector Market Size and Growth Rate of Adenoviral Vectors from 2016 to 2027

      • 1.3.3 USA Genetic Virus Vector Market Size and Growth Rate of Adeno-Associated Viral Vectors from 2016 to 2027

      • 1.3.4 USA Genetic Virus Vector Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Genetic Virus Vector Market Size and Growth Rate of Gene Therapy from 2016 to 2027

      • 1.4.2 USA Genetic Virus Vector Market Size and Growth Rate of Vaccinology from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Genetic Virus Vector Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Genetic Virus Vector Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Genetic Virus Vector Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Genetic Virus Vector Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Genetic Virus Vector Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Genetic Virus Vector by Major Types

      • 3.4.1 Market Size and Growth Rate of Retroviral Vectors

      • 3.4.2 Market Size and Growth Rate of Adenoviral Vectors

      • 3.4.3 Market Size and Growth Rate of Adeno-Associated Viral Vectors

      • 3.4.4 Market Size and Growth Rate of Other

    4 Segmentation of Genetic Virus Vector Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Genetic Virus Vector by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Genetic Virus Vector in Gene Therapy

      • 4.4.2 Market Size and Growth Rate of Genetic Virus Vector in Vaccinology

    5 Market Analysis by Regions

    • 5.1 USA Genetic Virus Vector Production Analysis by Regions

    • 5.2 USA Genetic Virus Vector Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Genetic Virus Vector Landscape Analysis

    • 6.1 West USA Genetic Virus Vector Landscape Analysis by Major Types

    • 6.2 West USA Genetic Virus Vector Landscape Analysis by Major End-Users

    7 South USA Genetic Virus Vector Landscape Analysis

    • 7.1 South USA Genetic Virus Vector Landscape Analysis by Major Types

    • 7.2 South USA Genetic Virus Vector Landscape Analysis by Major End-Users

    8 Middle West USA Genetic Virus Vector Landscape Analysis

    • 8.1 Middle West USA Genetic Virus Vector Landscape Analysis by Major Types

    • 8.2 Middle West USA Genetic Virus Vector Landscape Analysis by Major End-Users

    9 Northeast USA Genetic Virus Vector Landscape Analysis

    • 9.1 Northeast USA Genetic Virus Vector Landscape Analysis by Major Types

    • 9.2 Northeast USA Genetic Virus Vector Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Oxford BioMedica

        • 10.1.1 Oxford BioMedica Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Brammer Bio

        • 10.2.1 Brammer Bio Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 REGENXBIO Inc, Kaneka Eurogentec SA

        • 10.3.1 REGENXBIO Inc, Kaneka Eurogentec SA Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 uniQure NV

        • 10.4.1 uniQure NV Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Cobra Biologics

        • 10.5.1 Cobra Biologics Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Cell and Gene Therapy Catapult

        • 10.6.1 Cell and Gene Therapy Catapult Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 GENERAL ELECTRIC COMPANY

        • 10.7.1 GENERAL ELECTRIC COMPANY Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 FUJIFILM Diosynth Biotechnologies USA, Sanofi

        • 10.8.1 FUJIFILM Diosynth Biotechnologies USA, Sanofi Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Lonza

        • 10.9.1 Lonza Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Merck KGaA

        • 10.10.1 Merck KGaA Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 FinVector Vision Therapies

        • 10.11.1 FinVector Vision Therapies Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Spark Therapeutics

        • 10.12.1 Spark Therapeutics Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Genetic Virus Vector Market Size and Growth Rate of Retroviral Vectors from 2016 to 2027

    • Figure USA Genetic Virus Vector Market Size and Growth Rate of Adenoviral Vectors from 2016 to 2027

    • Figure USA Genetic Virus Vector Market Size and Growth Rate of Adeno-Associated Viral Vectors from 2016 to 2027

    • Figure USA Genetic Virus Vector Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Genetic Virus Vector Market Size and Growth Rate of Gene Therapy from 2016 to 2027

    • Figure USA Genetic Virus Vector Market Size and Growth Rate of Vaccinology from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Genetic Virus Vector Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Genetic Virus Vector Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Genetic Virus Vector Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Genetic Virus Vector Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Genetic Virus Vector Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Genetic Virus Vector

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Genetic Virus Vector by Different Types from 2016 to 2027

    • Table Consumption Share of Genetic Virus Vector by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Retroviral Vectors

    • Figure Market Size and Growth Rate of Adenoviral Vectors

    • Figure Market Size and Growth Rate of Adeno-Associated Viral Vectors

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Genetic Virus Vector by Different End-Users from 2016 to 2027

    • Table Consumption Share of Genetic Virus Vector by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Gene Therapy

    • Figure Market Size and Growth Rate of Vaccinology

    • Table USA Genetic Virus Vector Production by Regions

    • Table USA Genetic Virus Vector Production Share by Regions

    • Figure USA Genetic Virus Vector Production Share by Regions in 2016

    • Figure USA Genetic Virus Vector Production Share by Regions in 2021

    • Figure USA Genetic Virus Vector Production Share by Regions in 2027

    • Table USA Genetic Virus Vector Consumption by Regions

    • Table USA Genetic Virus Vector Consumption Share by Regions

    • Figure USA Genetic Virus Vector Consumption Share by Regions in 2016

    • Figure USA Genetic Virus Vector Consumption Share by Regions in 2021

    • Figure USA Genetic Virus Vector Consumption Share by Regions in 2027

    • Table West USA Genetic Virus Vector Consumption by Types from 2016 to 2027

    • Table West USA Genetic Virus Vector Consumption Share by Types from 2016 to 2027

    • Figure West USA Genetic Virus Vector Consumption Share by Types in 2016

    • Figure West USA Genetic Virus Vector Consumption Share by Types in 2021

    • Figure West USA Genetic Virus Vector Consumption Share by Types in 2027

    • Table West USA Genetic Virus Vector Consumption by End-Users from 2016 to 2027

    • Table West USA Genetic Virus Vector Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Genetic Virus Vector Consumption Share by End-Users in 2016

    • Figure West USA Genetic Virus Vector Consumption Share by End-Users in 2021

    • Figure West USA Genetic Virus Vector Consumption Share by End-Users in 2027

    • Table South USA Genetic Virus Vector Consumption by Types from 2016 to 2027

    • Table South USA Genetic Virus Vector Consumption Share by Types from 2016 to 2027

    • Figure South USA Genetic Virus Vector Consumption Share by Types in 2016

    • Figure South USA Genetic Virus Vector Consumption Share by Types in 2021

    • Figure South USA Genetic Virus Vector Consumption Share by Types in 2027

    • Table South USA Genetic Virus Vector Consumption by End-Users from 2016 to 2027

    • Table South USA Genetic Virus Vector Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Genetic Virus Vector Consumption Share by End-Users in 2016

    • Figure South USA Genetic Virus Vector Consumption Share by End-Users in 2021

    • Figure South USA Genetic Virus Vector Consumption Share by End-Users in 2027

    • Table Middle West USA Genetic Virus Vector Consumption by Types from 2016 to 2027

    • Table Middle West USA Genetic Virus Vector Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Genetic Virus Vector Consumption Share by Types in 2016

    • Figure Middle West USA Genetic Virus Vector Consumption Share by Types in 2021

    • Figure Middle West USA Genetic Virus Vector Consumption Share by Types in 2027

    • Table Middle West USA Genetic Virus Vector Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Genetic Virus Vector Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Genetic Virus Vector Consumption Share by End-Users in 2016

    • Figure Middle West USA Genetic Virus Vector Consumption Share by End-Users in 2021

    • Figure Middle West USA Genetic Virus Vector Consumption Share by End-Users in 2027

    • Table Northeast USA Genetic Virus Vector Consumption by Types from 2016 to 2027

    • Table Northeast USA Genetic Virus Vector Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Genetic Virus Vector Consumption Share by Types in 2016

    • Figure Northeast USA Genetic Virus Vector Consumption Share by Types in 2021

    • Figure Northeast USA Genetic Virus Vector Consumption Share by Types in 2027

    • Table Northeast USA Genetic Virus Vector Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Genetic Virus Vector Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Genetic Virus Vector Consumption Share by End-Users in 2016

    • Figure Northeast USA Genetic Virus Vector Consumption Share by End-Users in 2021

    • Figure Northeast USA Genetic Virus Vector Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Oxford BioMedica

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Oxford BioMedica

    • Figure Sales and Growth Rate Analysis of Oxford BioMedica

    • Figure Revenue and Market Share Analysis of Oxford BioMedica

    • Table Product and Service Introduction of Oxford BioMedica

    • Table Company Profile and Development Status of Brammer Bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Brammer Bio

    • Figure Sales and Growth Rate Analysis of Brammer Bio

    • Figure Revenue and Market Share Analysis of Brammer Bio

    • Table Product and Service Introduction of Brammer Bio

    • Table Company Profile and Development Status of REGENXBIO Inc, Kaneka Eurogentec SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of REGENXBIO Inc, Kaneka Eurogentec SA

    • Figure Sales and Growth Rate Analysis of REGENXBIO Inc, Kaneka Eurogentec SA

    • Figure Revenue and Market Share Analysis of REGENXBIO Inc, Kaneka Eurogentec SA

    • Table Product and Service Introduction of REGENXBIO Inc, Kaneka Eurogentec SA

    • Table Company Profile and Development Status of uniQure NV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of uniQure NV

    • Figure Sales and Growth Rate Analysis of uniQure NV

    • Figure Revenue and Market Share Analysis of uniQure NV

    • Table Product and Service Introduction of uniQure NV

    • Table Company Profile and Development Status of Cobra Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cobra Biologics

    • Figure Sales and Growth Rate Analysis of Cobra Biologics

    • Figure Revenue and Market Share Analysis of Cobra Biologics

    • Table Product and Service Introduction of Cobra Biologics

    • Table Company Profile and Development Status of Cell and Gene Therapy Catapult

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cell and Gene Therapy Catapult

    • Figure Sales and Growth Rate Analysis of Cell and Gene Therapy Catapult

    • Figure Revenue and Market Share Analysis of Cell and Gene Therapy Catapult

    • Table Product and Service Introduction of Cell and Gene Therapy Catapult

    • Table Company Profile and Development Status of GENERAL ELECTRIC COMPANY

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GENERAL ELECTRIC COMPANY

    • Figure Sales and Growth Rate Analysis of GENERAL ELECTRIC COMPANY

    • Figure Revenue and Market Share Analysis of GENERAL ELECTRIC COMPANY

    • Table Product and Service Introduction of GENERAL ELECTRIC COMPANY

    • Table Company Profile and Development Status of FUJIFILM Diosynth Biotechnologies USA, Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of FUJIFILM Diosynth Biotechnologies USA, Sanofi

    • Figure Sales and Growth Rate Analysis of FUJIFILM Diosynth Biotechnologies USA, Sanofi

    • Figure Revenue and Market Share Analysis of FUJIFILM Diosynth Biotechnologies USA, Sanofi

    • Table Product and Service Introduction of FUJIFILM Diosynth Biotechnologies USA, Sanofi

    • Table Company Profile and Development Status of Lonza

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lonza

    • Figure Sales and Growth Rate Analysis of Lonza

    • Figure Revenue and Market Share Analysis of Lonza

    • Table Product and Service Introduction of Lonza

    • Table Company Profile and Development Status of Merck KGaA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA

    • Figure Sales and Growth Rate Analysis of Merck KGaA

    • Figure Revenue and Market Share Analysis of Merck KGaA

    • Table Product and Service Introduction of Merck KGaA

    • Table Company Profile and Development Status of FinVector Vision Therapies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of FinVector Vision Therapies

    • Figure Sales and Growth Rate Analysis of FinVector Vision Therapies

    • Figure Revenue and Market Share Analysis of FinVector Vision Therapies

    • Table Product and Service Introduction of FinVector Vision Therapies

    • Table Company Profile and Development Status of Spark Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spark Therapeutics

    • Figure Sales and Growth Rate Analysis of Spark Therapeutics

    • Figure Revenue and Market Share Analysis of Spark Therapeutics

    • Table Product and Service Introduction of Spark Therapeutics


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.